about
Inverted double-gap isolation chamber for high-resolution calcium fluorimetry in skeletal muscle fibers.Calcium-triggered short-coupled polymorphous ventricular tachycardia.Supercharging accelerates T-tubule membrane potential changes in voltage clamped frog skeletal muscle fibers.Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical Evaluation.Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization.Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.Examination of the Human Cytochrome P4503A4 Induction Potential of PF-06282999, an Irreversible Myeloperoxidase Inactivator: Integration of Preclinical, In Silico, and Biomarker Methodologies in the Prediction of the Clinical Outcome.New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.Arrhythmogenesis by single ectopic beats originating in the Purkinje system.Prospective observations in the clinical and electrophysiological characteristics of intra-isthmus reentry.Fast voltage gating of Ca2+ release in frog skeletal muscle revealed by supercharging pulses.Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates.Microfibrosis and complex fractionated atrial electrogramsPharmacokinetics, pharmacodynamics, and safety of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, in healthy subjects when administered in co-mixture with recombinant human hyaluronidase: A phase 1 randomizeTargeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis
P50
Q30731018-33BDBA41-F380-4AC9-8B96-59B34DAACBCDQ33158704-3D63DFEF-A14A-4191-B244-97C88F68B68CQ34169240-14270A7A-ABC6-4CA7-8C25-0D770D6EBF2CQ35698299-A36FE3CD-14BF-4D78-975C-140317DACBF2Q37407596-9AD5CC87-1D9E-4721-B853-5962CC2A497CQ38806549-F02149E7-D832-4060-BCF1-21D7111EE882Q38932273-CAC78B93-23A6-4401-B35B-11515DD36534Q38955252-318E84D3-FE1E-42EF-B1CE-F020571A4D52Q42243303-2FDC8D59-957E-4835-A6FC-BCAA65F16F83Q46281438-1290E555-9899-475C-A3A4-1A90DDBCCE68Q46479502-733992CE-E3F3-4C2F-909D-0B4FADC6C144Q47209022-8D93CC5E-E234-402A-B7F7-2B8E71091CABQ83902685-9088F4E2-8DE2-4F4C-A31C-5E8F26A8DFC7Q90953456-7A2896C3-0F4A-446F-B921-4BACBAF89C36Q91496257-C3294BED-5372-4E8F-ADD2-A9878B42892D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Albert M Kim
@ast
Albert M Kim
@en
Albert M Kim
@es
Albert M Kim
@nl
type
label
Albert M Kim
@ast
Albert M Kim
@en
Albert M Kim
@es
Albert M Kim
@nl
prefLabel
Albert M Kim
@ast
Albert M Kim
@en
Albert M Kim
@es
Albert M Kim
@nl
P106
P108
P1153
36781507800
P21
P31
P496
0000-0002-5269-2155